Latest market data
| Close | 8.53 (-1.5% on the day; -11.42% over 5 sessions; -6.78% over 20 sessions) |
|---|---|
| Market cap | CNY 5.80 billion |
| P/E (TTM) | 23.64x (65th percentile over 5.2 years) |
| P/B (MRQ) | 2.97x (41th percentile over 5.2 years) |
| P/S (TTM) | 1.28x (28th percentile over 5.2 years) |
| 52-week range | 8.28 (2026-07-21) – 16.88 (2026-05-18) |
| Moving averages | MA5 8.85 / MA10 9.12 / MA20 9.05 / MA60 9.87 |
| MACD (12,26,9) | DIF -0.204, DEA -0.177, histogram -0.053 |
| RSI | RSI6 28.4 / RSI14 37.7 |
| Bollinger bands (20,2) | Upper 9.7 / middle 9.05 / lower 8.4 |
| Volume | 0.48x the 20-day average |
| One-week range (about 68% coverage) | 8.04 – 9.1 (-5.7% ~ +6.7%) |
| One-week range (about 95% coverage) | 7.59 – 10.39 (-11.0% ~ +21.8%) |
As of the 2026-11-18 close; calculated from daily price data (adjusted prices) and refreshed automatically each trading day. The one-week range reflects historical volatility only and is not a forecast. The report below was written on 2026-10-01; its prices and short-term scenarios reflect data at that time.
Jiangsu Chengxing Phosph-Chemical Co., Ltd. (600078)
Stock Analysis Report | Industry: Phosphorus Chemical | Report Date: October 1, 2026 | Market and Technical Indicators as of the Close on September 30, 2026
This report is automatically compiled and generated by AI based on public information, for reference only, and does not constitute investment advice.
Core Conclusion: Profitability has rebounded from the trough, but whether the recovery can be sustained remains to be verified, and the valuation already demands relatively high growth
| Key Data | Value |
|---|---|
| Closing Price (Daily Change) | RMB 9.79 (+0.1%) |
| Total Market Cap | Approx. RMB 6.654 billion |
| PE(TTM) | 61.87x |
| PB(MRQ) | 3.7x |
| 52-Week Range | RMB 6.21–16.88 |
| Turnover / Turnover Rate | RMB 47.513 million / 0.73% |
Market data as of: Market and technical indicators as of the close on September 30, 2026
1. Key Investment Points
- Profitability has significantly recovered from the cyclical trough: H1 2026 revenue was RMB 2.138 billion, up 20.37% YoY; net profit attributable to parent was RMB 117.63 million, up 533.75% YoY; non-recurring profit turned from loss to profit, but the YoY growth rate is affected by a low base.
- The recovery still depends on prices, and idle capacity remains to be realized: H1 gross margin rose to 19.09%, driven by yellow phosphorus and phosphoric acid prices and cost control; phosphoric acid capacity utilization was only 46.42%, and phosphate salts only 14.53%.
- The stock price corresponds to a high PE, and the valuation demands are relatively high: Closing price on September 30 was RMB 9.79, PE-TTM 61.87x, PB 3.7x; there is no verifiable consensus estimate or target price, making direct comparison with forward PE difficult.
Market Expectations and Evidence
- The market is pricing in: The 61.87x PE implies an average annual EPS growth of approximately 24.4% over the next 10 years (assuming an 8% annualized return and a terminal PE of 15x); there is no verifiable consensus estimate, so it cannot be determined whether the requirement is above or below institutional expectations.
- Evidence shows: H1 revenue grew 20.37% and gross margin rose to 19.09%, confirming the earnings recovery; however, the improvement is mainly driven by product prices and costs, and the full-year sustainability, conversion of low-utilization capacity, and the 24.4% long-term growth requirement remain to be verified.
Evidence leaning: Balanced; Confidence: Medium
The H1 earnings and gross margin improvement is clear, but the main drivers are cyclical, and full-year performance and institutional consensus estimates are not yet verifiable.
2. Business and Competitiveness
2.1 Business Structure
The company produces and sells phosphorus chemical products such as yellow phosphorus, phosphoric acid, and phosphate salts. Revenue mainly comes from yellow phosphorus and phosphoric acid, and profitability is affected by product prices and raw material and energy costs.
| Business Segment | Revenue Share | Gross Margin | Revenue Growth | Key Points |
|---|---|---|---|---|
| Yellow Phosphorus | 48.9% (2025 main business revenue) | 17.15% (2025) | 6.40% (2025 YoY) | Capacity utilization 94.75%, output 151,600 tons. |
| Phosphoric Acid | 45.8% (2025 main business revenue) | 5.25% (2025) | 13.86% (2025 YoY) | Capacity utilization 46.42%, nominal capacity not fully converted into effective supply. |
| Phosphate Salts | 3.0% (2025 main business revenue) | 11.21% (2025) | -29.72% (2025 YoY) | Capacity utilization 14.53%, completion time of relocation project uncertain. |
| Other Chemical Products | 2.3% (2025 main business revenue) | 25.29% (2025) | 27.84% (2025 YoY) | Revenue scale is relatively small. |
2.2 Competitive Advantages
Competitive Advantage Strength: Weak
- Some self-owned phosphate mines and supporting hydropower and thermal power; mines mainly meet self-use, self-sufficiency rate not disclosed.
- Yellow phosphorus designed capacity of 160,000 tons/year, 2025 output of 151,600 tons, utilization rate 94.75%.
- Disclosed products such as food-grade and electronic-grade phosphoric acid and long-term customer cooperation, but customer-side certification and premium not quantified.
Main threats: Fluctuations in yellow phosphorus and phosphoric acid prices and ore and energy costs; low utilization of phosphoric acid and phosphate salts, plus safety, environmental, and relocation risks.
2.3 Industry Chain Position and Profit Trend
- Main inputs include phosphate rock, coke breeze, electrodes, thermal coal, and electricity; phosphoric acid uses yellow phosphorus as raw material, and phosphate salts also use phosphoric acid, soda ash, and calcium carbonate.
- In 2025, direct materials accounted for 91.29% of chemical main business costs; phosphate rock procurement price rose 10.43% YoY, coke breeze fell 20.55%, electricity fell 6.20%. The company has some self-owned mines and electricity but still needs external procurement, with limited pricing power over inputs.
- Products are used in thermal phosphoric acid and chemical intermediates, food industry, daily chemicals, metal phosphating, and cathode materials; fine-grade products may create differentiation, but the premium is not quantified.
- Yellow phosphorus and phosphoric acid are affected by market supply and demand and raw material costs, with limited product pricing influence; customer list and payment terms not disclosed, making it difficult to judge specific customer bargaining power.
- The 2025 annual report disclosed that the top five customers accounted for 21.68% of sales, and the top five suppliers accounted for 32.94% of procurement; no independent cross-verification was seen, and specifics should be based on the latest annual report.
- At end-2025, accounts receivable were approximately RMB 104 million, 2.90% of revenue and approximately 1.05x consolidated net profit; notes receivable were RMB 877 million, up 63.85% YoY; prepayments were RMB 22.2879 million, up 215.16% YoY; net operating cash flow was RMB 377 million.
| Year | Gross Margin | Net Margin | Reason for Change |
|---|---|---|---|
| 2022 | Approx. 21.77% | Approx. 11.50% (attributable to parent) | Phosphorus chemical industry boom, good product gross margin. |
| 2023 | Approx. 9.78% | Approx. -1.96% (attributable to parent) | Product prices fell, phosphoric acid under pressure with inventory write-downs. |
| 2024 | Approx. 6.94% | Approx. -5.93% (attributable to parent) | Weak demand, yellow phosphorus prices moved lower, phosphate rock costs at high levels. |
| 2025 | Approx. 11.82% | Approx. 0.24% (attributable to parent) | Yellow phosphorus and phosphoric acid gross margin recovered, non-recurring losses persisted. |
The company is positioned in the midstream phosphorus chemical segment, based on yellow phosphorus and extending to thermal phosphoric acid and phosphate salts, with profits affected by cyclical prices and input costs. Further improvement depends on raising phosphoric acid and phosphate salt utilization, stabilizing ore and energy costs, and verifying fine product premiums.
2.4 Industry and Peer Comparison
The phosphorus chemical industry is in cyclical fluctuation. In 2025, Chengxing's gross margin recovered but non-recurring profit remained at a loss; the key variables facing the company are the spread between product prices and raw material and energy costs, and whether low-utilization capacity can be converted into profit.
| Company | Positioning | Comparable Data | Difference from This Company |
|---|---|---|---|
| Chuanjinnuo (300505) | Phosphoric acid and phosphate salt products overlap with Chengxing. | 2025 revenue RMB 4.075 billion; company-wide gross margin approx. 18.0%; PE-TTM non-recurring 13.24x (September 18) | Products are relatively close, but business structure differs; valuation date is not September 30. |
| Chuanheng Co., Ltd. (002895) | Mining resources and phosphorus chemicals, feed-grade products. | 2025 revenue RMB 8.328 billion; phosphorus chemical gross margin 26.38%; PE-TTM approx. 14.32x (September 30) | Higher proportion of mining resources and feed-grade products. |
| Xingfa Group (600141) | Phosphate rock resources, diversified phosphorus chemical chain. | 2025 revenue RMB 29.300 billion; combined gross margin of the three main business categories approx. 18.0%; P/E 20.08x (September 30) | Significantly larger scale, business covers mining, pesticides, new energy materials, etc. |
| Chuanfa Longmang (002312) | Phosphate salts, fertilizers, and new energy materials. | 2025 revenue RMB 9.956 billion; gross margin —; PE-TTM non-recurring approx. 40.10x (September 18) | Product chain leans more toward phosphate salts, fertilizers, and new energy materials. |
Chengxing's yellow phosphorus scale and mine-power supporting facilities form a certain integration foundation, and its product structure is more concentrated in yellow phosphorus and thermal phosphoric acid than Chuanheng and Xingfa; however, self-owned mine coverage and fine product premiums are not quantified, and phosphoric acid and phosphate salt utilization are low. Peer resource endowments and business combinations differ significantly, so gross margins and valuations should not be directly compared horizontally.
3. Financial Quality
3.1 Operating Performance
| Reporting Period | Revenue | YoY | Net Profit Attributable to Parent | YoY | Non-Recurring YoY | Gross Margin |
|---|---|---|---|---|---|---|
| H1 2026 | RMB 2.138 billion | 20.37% | RMB 117.63 million | 533.75% | 453.64% (loss to profit) | 19.09% |
| 2025 Annual | RMB 3.596 billion | 7.16% | RMB 8.47 million | 104.26% (loss to profit) | 75.29% (loss narrowed) | 11.8% |
| 2024 Annual | RMB 3.356 billion | 8.22% | RMB -198.90 million | — | — | 6.94% |
As of 2026-10-01; H1 2026 gross margin calculated based on revenue and cost.
H1 earnings recovered significantly, mainly driven by higher yellow phosphorus and phosphoric acid prices, increased phosphoric acid sales volume, and cost control; non-recurring profit turned from loss to profit, and the reported YoY 453.64% is affected by the negative base.
3.2 Financial Health Check
| Indicator | Value | Assessment | Explanation |
|---|---|---|---|
| Debt-to-Asset Ratio | 64.0% (mid-2026) | Watch | Relatively high debt ratio, current liabilities exceed current assets. |
| Current Ratio / Cash Ratio | 0.85/0.28 (mid-2026) | Watch | Current assets insufficient to cover current liabilities. |
| Operating Cash Flow / Net Profit Attributable to Parent | 1.92x (H1 2026) | Good | Operating cash flow provides strong coverage of current-period profit. |
| Weighted Average ROE | 6.77% (H1 2026) | Average | Improved from 1.11% in the same period last year, full-year sustainability to be verified. |
| Accounts Receivable Bad Debt | RMB 23.6089 million (end-2025) | Watch | There are amounts expected to be uncollectible and fully provided for. |
4. Valuation and Market Expectations
4.1 Valuation Level
| Indicator | Current | Own History | Peer Comparison |
|---|---|---|---|
| PE(TTM) | 61.87x | 69th percentile over past 5.2 years (median 12.06x) | Approx. 9.53–20.88x, peer calculation methods differ |
| PB(MRQ) | 3.7x | 56th percentile over past 5.2 years (median 3.26x) | Approx. 1.4–2.46x |
| PS(TTM) | 1.68x | 57th percentile over past 5.2 years (median 1.58x) | — |
| Dividend Yield | 0% | — | — |
Valuation multiples calculated programmatically based on September 30, 2026 closing data (trailing twelve months basis)
Market-implied expectation: At the current 61.87x P/E, if investors require an 8% annualized return and a 15x P/E valuation after 10 years, EPS needs to grow approximately 24.4% annually (excluding dividends, relatively conservative), which can be compared with the consensus growth rate below.
PE-TTM of 61.87x is at the 69th percentile over the past 5.2 years, significantly above the historical median of 12.06x; PB of 3.7x is at the 56th percentile and PS of 1.68x at the 57th percentile, both slightly above their respective medians. The PE implies a requirement of approximately 24.4% average annual EPS growth, while institutional consensus estimates are missing; the current valuation already places relatively high demands on sustained earnings recovery.
4.3 Institutional Views
No verifiable target price; Tonghuashun has no ratings over the past 60 trading days, and the Sina page claims there are reports but does not show the institution, date, or rating.
5. Catalysts and Recent Events
5.1 Future Key Milestones
| Time | Event | Key Points |
|---|---|---|
| 2026-10-28 (Q3 report scheduled disclosure) | Q3 report disclosure and verification of operating continuity | Focus on whether earnings can continue H1 growth, changes in product prices and raw material costs, and the impact after Xuzhou Hongda is consolidated; actual contribution has no public quantitative expectation. |
5.2 Recent Important Events
- 2026-08-18 Interim report net profit up 533.75% YoY (positive): H1 revenue RMB 2.138 billion, net profit attributable to parent RMB 117.6 million, up 20.37% and 533.75% YoY respectively; average prices of yellow phosphorus and phosphoric acid rose YoY, phosphate rock costs increased, and the report and operating data are unaudited.
- 2026-09-30 Xuzhou Hongda completed industrial and commercial registration change (neutral): The company previously invested RMB 95.14 million to acquire a 45% equity interest in Xuzhou Hongda, which will be consolidated after the industrial and commercial registration change is completed; no quantifiable production, order, or profit contribution has been disclosed so far.
- 2026-09-22 Relocation compensation receivable pledged and new guarantee added (neutral): The company used RMB 401.93 million of relocation compensation receivables to support a total of RMB 150 million in credit facilities; it also provided a guarantee for a subsidiary's RMB 80 million credit facility, assuming a maximum principal balance of RMB 44 million. The compensation payment is still pending completion of relocation acceptance and other procedures.
6. Bull-Bear Divergence and Risks
6.1 Bull Case
- H1 2026 net profit attributable to parent was RMB 117.63 million, up 533.75% YoY, non-recurring profit turned around, and operating cash flow was 1.92x net profit.
- Yellow phosphorus capacity utilization has reached 94.75%; if the spread between product prices and costs continues to improve, the H1 gross margin of 19.09% is expected to support earnings recovery.
6.2 Bear Case
- PE-TTM of 61.87x is at the 69th percentile over the past 5.2 years, implying approximately 24.4% average annual EPS growth, higher than the currently disclosed revenue growth of 20.37%.
- Phosphoric acid and phosphate salt utilization are only 46.42% and 14.53% respectively; phosphate salt revenue fell 29.72% YoY in 2025, and inefficient capacity has not yet formed a profit contribution.
6.3 Other Risks
- Mid-2026 debt-to-asset ratio 64%, current ratio 0.85, cash ratio 0.28 → short-term debt repayment pressure may raise financial expenses and limit operating flexibility.
- RMB 401.93 million relocation compensation receivable is still pending payment after acceptance and other procedures, and is used to support RMB 150 million in credit facilities → delayed collection may increase capital occupation and suppress cash flow.
- End-2025 accounts receivable bad debt of RMB 23.6089 million has been fully provided for → if collection quality continues to deteriorate, new impairments will erode profits.
7. Tracking List
| Tracking Indicator | Current | Bullish Verification | Bearish Verification |
|---|---|---|---|
| Q3 report earnings continuity | Scheduled for disclosure on October 28, 2026 | Quarterly earnings continue and gross margin remains around 19% | Quarterly profit declines significantly or gross margin falls below 15% |
| Phosphoric acid and phosphate salt utilization | 46.42% and 14.53% respectively | Both utilization rates continue to rise and drive segment profitability to turn positive | Utilization stagnates or declines, inefficient capacity continues to drag on profit |
| Operating cash flow and short-term debt repayment | H1 cash flow/net profit 1.92x; current ratio 0.85 | Operating cash flow continues to cover profit, current ratio rebounds above 1 | Cash flow weakens and current ratio declines further |
| Relocation compensation and Xuzhou Hongda contribution | Compensation pending acceptance and payment; 45% equity in Xuzhou Hongda consolidated | Compensation received, or quantifiable production and profit contribution disclosed | Collection continues to be delayed, no visible profit contribution after consolidation |
8. Stock Price and Short-Term Outlook (Next Week, Scenario Projection, for Reference Only)
⚠️ ⚠️Risk Warning: The following are subjective heuristic scenario weights, not statistical probabilities, and do not constitute investment advice.****
8.1 Technical Overview
The stock price is below short- and medium-term moving averages, MACD remains negative, and the technical picture is weak; RSI6 is at a low level but has not confirmed a reversal. The full text of the September 30 outbound investment progress announcement has not been verified and is temporarily not included in the catalyst assessment.
| Indicator | Value | Interpretation |
|---|---|---|
| 5/20-day Change | -5.04%/-12.35% | Recent decline is evident, short-term weak. |
| MA5/10/20/60 | MA5 9.85 | Stock price is below all moving averages, which form overhead resistance. |
| Bollinger Upper/Middle/Lower Bands | Upper 11.37 / Middle 10.4 / Lower 9.44 | Close to the lower band, rebound still needs to reclaim the middle band. |
| MACD DIF/DEA/Histogram | DIF -0.273 / DEA -0.202 / Histogram -0.142 | Histogram narrowed from the previous day but remains negative, reversal not confirmed. |
| RSI6/RSI14 | RSI6 29.3 / RSI14 36.7 | Short-cycle at a relatively low level, temporarily insufficient to confirm a bottom. |
8.2 Key Price Levels
| Level | Range | Explanation |
|---|---|---|
| Short-term Resistance | RMB 10.05–10.40 | Corresponds to MA10 and MA20/60; only after a valid hold can higher resistance zones be observed. |
| First Support | RMB 9.55–9.80 | Corresponds to the recent low of RMB 9.56 and near the closing price; if broken, watch the Bollinger lower band area. |
| Strong Support | RMB 9.40–9.56 | Corresponds to the Bollinger lower band of RMB 9.44 and the recent low; after a break, lower support needs to be assessed using longer-cycle structures. |
8.3 One-Week Range Calculated by Historical Volatility
Using the September 30, 2026 price of RMB 9.79 as the baseline, the future 5-trading-day closing price range is projected using the return distribution over the past 300 trading days (scaled by the current index-weighted daily volatility of approximately 2.5%, retaining this stock's own frequency of large gains and losses):
| Coverage Probability | Price Range | Relative to Baseline |
|---|---|---|
| Approx. 68% | RMB 9.31–10.43 | -4.9%–+6.5% |
| Approx. 95% | RMB 8.9–11.57 | -9.1%–+18.2% |
This range only reflects the stock's recent volatility magnitude and does not include a directional judgment; in the event of major announcements or a sharp market decline, actual movements may still exceed the range.
8.4 Next-Week Scenarios (Subjective Weights, Not Statistical Probabilities)
- Consolidation (relatively high weight, approx. 50%): Holds RMB 9.55–9.80 without a volume-driven decline, market and sector do not weaken significantly, watch the RMB 9.44–10.40 range.
- Weak downside (medium weight, approx. 30%): Breaks below RMB 9.40–9.56 on volume with continued capital outflow, may seek support in the RMB 9.00–9.40 range.
- Rebound strength (relatively low weight, approx. 20%): After holding RMB 9.55–9.80, reclaims RMB 10.05–10.40 on volume, and the broader market or phosphorus chemical sector stabilizes, watch RMB 10.40–11.37.
8.5 Capital and Liquidity
As of September 30, 2026, turnover rate was 0.73% and turnover was RMB 47.513 million; recent daily turnover is estimated at approximately RMB 47 million–360 million. The June 30, 2026 interim report showed the top ten shareholders held approximately 44.51% in total, with the top two holding 40.92%; public funds and overseas institution/nominee accounts are visible, but individual holdings are relatively low, and the structure may have changed. Trading depth may weaken at low volumes, and larger orders may widen price impact and slippage.
If daily turnover reaches approximately RMB 200 million or more for two consecutive trading days and the price reclaims RMB 10.05–10.40, this can be viewed as a signal of improved capital participation.
The above scenario projection is based on September 30, 2026 closing data and historical price and technical indicator calculations. Short-term stock prices will also be affected by multiple factors such as news, capital flows, and the broader market environment. Technical indicators themselves have lag and limitations, do not guarantee actual future movements, and do not constitute buy or sell advice. Please combine the latest market information to make independent judgments and bear investment risks yourself.
Sources
- 上市公司按地区查询结果 | 上海证券交易所
- 江苏澄星磷化工股份有限公司2025年年度报告
- 澄星股份(600078)_公司公告_澄星股份:2025年年度报告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:2024年年度报告新浪财经_新浪网
- 川金诺(300505)_公司公告_川金诺:2025年年度报告新浪财经_新浪网
- 川恒股份(002895)_公司公告_川恒股份:2025年年度报告新浪财经_新浪网
- 兴发集团(600141)_公司公告_兴发集团:2025年年度报告新浪财经_新浪网
- 川发龙蟒(002312)_公司公告_川发龙蟒:2025年年度报告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:2026年半年度报告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:2026年半年度业绩预告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:关于2025年度拟不进行利润分配的公告新浪财经_新浪网
- 云天化(600096)_股票行情,行情首页_中财网
- 澄星股份(600078) 盈利预测_F10_同花顺金融服务网
- 澄星股份(600078)股票股价,行情,新闻,财报数据_新浪财经_新浪网
- 澄星股份(600078)市盈率|估值|基本面 - 理杏仁
- 证券代码:600078 证券简称:澄星股份 公告编号:临 2026-029
- 澄星股份(600078)_公司公告_澄星股份:2026年半年度主要经营数据公告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:关于子公司增资暨对外投资的公告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:关于江阴工厂停产的公告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:关于应收账款质押的公告新浪财经_新浪网
- 江苏澄星磷化工股份有限公司关于为控股子公司提供担保的进展公告_新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:关于向公司2025年限制性股票激励计划激励对象授予预留部分限制性股票的公告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:2026年第二次临时股东会决议公告新浪财经_新浪网
- 澄星股份(600078)_公司公告_澄星股份:2026年半年度报告摘要新浪财经_新浪网
- 澄星股份(600078)资金流向_个股行情_同花顺财经
- 股票行情快报:澄星股份(600078)9月30日主力资金净卖出248.54万元_主力研究_股票_证券之星
- 澄星股份(600078)_重大事项提醒与新闻公告_投资提醒_新浪财经_新浪网
- 9月30日澄星股份(600078)今日最新主力资金流向-kiss概念风向标
This report was automatically retrieved, compiled, and generated by AI based on public channel information, with information as of market and technical indicators as of the close on September 30, 2026. There may be timeliness differences, and specific data should be based on the company's official announcements and authoritative data terminals. This report is only for information compilation and research reference, does not constitute any investment advice, and investors should make independent judgments and bear investment risks themselves.
Model value range, DCF / industry models, comparable-company checks, confidence and key assumptions
- Price
- HK$301.00
- Low
- HK$313.08
- Base
- HK$433.53
- High
- HK$566.80